1. Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in Japan: Post hoc analysis of the LixiLan JP‐O2 trial. Issue 12 (23rd September 2021) Authors: Iizuka, Katsumi; Baxter, Mike; Watanabe, Daisuke; Yabe, Daisuke Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 12(2021) Page Start: 2795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benefits of the fixed‐ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes: A subgroup and time‐to‐control analysis of the LixiLan JP phase 3 trials. (16th September 2020) Authors: Terauchi, Yasuo; Yabe, Daisuke; Kaneto, Hideaki; Amano, Atsushi; Baxter, Mike; Watanabe, Daisuke; Watada, Hirotaka; Inagaki, Nobuya Journal: Diabetes, obesity & metabolism Issue: Volume 22:Supplement 4(2020) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exploring cutting structure in film, with applications to the films of D. W. Griffith, Mack Sennett, and Charlie Chaplin. (27th August 2015) Authors: Baxter, Mike; Khitrova, Daria; Tsivian, Yuri Journal: Digital scholarship in the humanties Issue: Volume 32:Number 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fixed‐ratio combination of basal insulin and glucagon‐like peptide‐1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge. (16th September 2020) Authors: Kaneto, Hideaki; Koshida, Ryusuke; Baxter, Mike Journal: Diabetes, obesity & metabolism Issue: Volume 22:Supplement 4(2020) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial. Issue 8 (18th June 2019) Authors: Davies, Melanie J.; Russell‐Jones, David; Barber, Thomas M.; Lavalle‐González, Fernando J.; Galstyan, Gagik R.; Zhu, Dalong; Baxter, Mike; Dessapt‐Baradez, Cecile; McCrimmon, Rory J. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 8(2019) Page Start: 1967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Glycaemic variability: The under‐recognized therapeutic target in type 1 diabetes care. Issue 12 (26th August 2019) Authors: Wilmot, Emma G.; Choudhary, Pratik; Leelarathna, Lalantha; Baxter, Mike Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 12(2019) Page Start: 2599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. IGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post‐hoc analysis of the LixiLan JP‐L trial. Issue 11 (19th June 2021) Authors: Yabe, Daisuke; Iizuka, Katsumi; Baxter, Mike; Watanabe, Daisuke; Kaneto, Hideaki Journal: Journal of diabetes investigation Issue: Volume 12:Issue 11(2021) Page Start: 1992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. On the distributional regularity of shot lengths in film. (29th June 2013) Authors: Baxter, Mike Journal: Digital scholarship in the humanties Issue: Volume 30:Number 1(2015) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pompeii, tombs and drinking habits: Archaeology counts. Issue 2 (25th April 2013) Authors: Baxter, Mike Journal: Significance Issue: Volume 10:Issue 2(2013:Jun.) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗